Home NDC 0173-0882 Breo Ellipta
Product NDC 0173-0882
11-digit product format 001730882
Labeler code 0173
Product ID 0173-0882_03107b41-0bf9-463a-a6e4-956444373e81
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name fluticasone furoate and vilanterol trifenatate
Dosage form POWDER
Route RESPIRATORY (INHALATION)
Labeler GlaxoSmithKline LLC
Application NDA204275
Marketing category NDA
Marketing start 2015-04-30
Substance FLUTICASONE FUROATE; VILANTEROL TRIFENATATE
Active strength 200; 25 ug/1; ug/1
Pharmacologic classes Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204275-001 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 N204275-002 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 N204275-003 BREO ELLIPTA FLUTICASONE FUROATE; VILANTEROL TRIFENATATE 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2023-05-12
Orange Book patents# Current patent rows page 1 of 1 · 30 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N204275-001 8511304 2027-06-14 U-1424 Drug product 2013-09-06 N204275-001 8511304 2027-06-14 U-1691 Drug product 2013-09-06 N204275-001 8511304 2027-06-14 U-3623 Drug product 2013-09-06 N204275-001 8511304*PED 2027-12-14 Pediatric extension N204275-001 11116721 2029-02-26 U-1401 Drug product 2021-10-12 N204275-001 11116721 2029-02-26 U-1691 Drug product 2021-10-12 N204275-001 11116721 2029-02-26 U-3623 Drug product 2021-10-12 N204275-001 11116721*PED 2029-08-26 Pediatric extension N204275-001 8534281 2030-03-08 Drug product 2013-09-18 N204275-001 8534281*PED 2030-09-08 Pediatric extension N204275-001 8746242 2030-10-11 Drug product 2014-07-08 N204275-001 8746242*PED 2031-04-11 Pediatric extension N204275-002 8511304 2027-06-14 U-1691 Drug product 2015-05-07 N204275-002 8511304 2027-06-14 U-3623 Drug product 2015-05-07 N204275-002 8511304*PED 2027-12-14 Pediatric extension N204275-002 11116721 2029-02-26 U-1691 Drug product 2021-10-12 N204275-002 11116721 2029-02-26 U-3623 Drug product 2021-10-12 N204275-002 11116721*PED 2029-08-26 Pediatric extension N204275-002 8534281 2030-03-08 Drug product 2015-05-07 N204275-002 8534281*PED 2030-09-08 Pediatric extension N204275-002 8746242 2030-10-11 Drug product 2015-05-07 N204275-002 8746242*PED 2031-04-11 Pediatric extension N204275-003 8511304 2027-06-14 U-3623 Drug product 2023-06-09 N204275-003 8511304*PED 2027-12-14 Pediatric extension N204275-003 11116721 2029-02-26 U-3623 Drug product 2023-06-09 N204275-003 11116721*PED 2029-08-26 Pediatric extension N204275-003 8534281 2030-03-08 Drug product 2023-06-09 N204275-003 8534281*PED 2030-09-08 Pediatric extension N204275-003 8746242 2030-10-11 Drug product 2023-06-09 N204275-003 8746242*PED 2031-04-11 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 107 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2023-05-12 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2023-05-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204275-002 BREO ELLIPTA 0.2MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2015-04-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204275-003 BREO ELLIPTA 0.05MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD 2023-05-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204275-001 BREO ELLIPTA 0.1MG/INH;EQ 0.025MG BASE/INH POWDER / INHALATION RLD, RS 2013-05-10 1e350fbaab3a…
Observed Orange Book patent history# Patent history page 1 of 45 · 1,785 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N204275-001 8511304 2027-06-14 U-1691 Drug product 2013-09-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8511304 2027-06-14 U-1424 Drug product 2013-09-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8511304 2027-06-14 U-3623 Drug product 2013-09-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8511304*PED 2027-12-14 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 11116721 2029-02-26 U-1401 Drug product 2021-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 11116721 2029-02-26 U-3623 Drug product 2021-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 11116721 2029-02-26 U-1691 Drug product 2021-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 11116721*PED 2029-08-26 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8534281 2030-03-08 Drug product 2013-09-18 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8534281*PED 2030-09-08 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8746242 2030-10-11 Drug product 2014-07-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-001 8746242*PED 2031-04-11 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8511304 2027-06-14 U-3623 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8511304 2027-06-14 U-1691 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8511304*PED 2027-12-14 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 11116721 2029-02-26 U-3623 Drug product 2021-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 11116721 2029-02-26 U-1691 Drug product 2021-10-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 11116721*PED 2029-08-26 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8534281 2030-03-08 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8534281*PED 2030-09-08 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8746242 2030-10-11 Drug product 2015-05-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-002 8746242*PED 2031-04-11 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 8511304 2027-06-14 U-3623 Drug product 2023-06-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 8511304*PED 2027-12-14 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 11116721 2029-02-26 U-3623 Drug product 2023-06-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 11116721*PED 2029-08-26 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 8534281 2030-03-08 Drug product 2023-06-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 8534281*PED 2030-09-08 Pediatric extension caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 8746242 2030-10-11 Drug product 2023-06-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204275-003 8746242*PED 2031-04-11 Pediatric extension caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204275-001 8511304 2027-06-14 U-1691 Drug product 2013-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 8511304 2027-06-14 U-1424 Drug product 2013-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 8511304 2027-06-14 U-3623 Drug product 2013-09-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 8511304*PED 2027-12-14 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 11116721 2029-02-26 U-1401 Drug product 2021-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 11116721 2029-02-26 U-3623 Drug product 2021-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 11116721 2029-02-26 U-1691 Drug product 2021-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 11116721*PED 2029-08-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 8534281 2030-03-08 Drug product 2013-09-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204275-001 8534281*PED 2030-09-08 Pediatric extension 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 96 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Breo Ellipta
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FLUTICASONE FUROATE 200 ug/1 VILANTEROL TRIFENATATE 25 ug/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination JS86977WNV Internal UNII lookup 40AHO2C6DG Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 10 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1424889 Internal RxNorm lookup 1424899 Internal RxNorm lookup 1539891 Internal RxNorm lookup 1539893 Internal RxNorm lookup 1648783 Internal RxNorm lookup 1648785 Internal RxNorm lookup 1648788 Internal RxNorm lookup 1648789 Internal RxNorm lookup 2637473 Internal RxNorm lookup 2637476 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0173-0882 BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE) POWDER [GLAXOSMITHKLINE LLC] 28 Current NDC, Legacy NDC, 6 package rows 20250521_96428df1-ea05-431a-98d3-1ec2c4b63878.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY DailyMed SPL version 1539891 Breo Ellipta 100/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539893 Breo Ellipta 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648785 Breo Ellipta 200/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648789 Breo Ellipta 200/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 2637476 Breo Ellipta 50/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 2637473 fluticasone furoate 0.05 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler, 30 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1424899 fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1424889 fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648783 fluticasone furoate/vilanterol 200/25 MCG/INHAL Dry Powder Inhaler, 14 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648788 fluticasone furoate/vilanterol 200/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters PSN 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539891 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] SBD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648785 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] SBD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 2637476 30 ACTUAT fluticasone furoate 0.05 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] SBD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539893 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] SBD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648789 30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Breo] SBD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1424899 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648783 14 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 2637473 30 ACTUAT fluticasone furoate 0.05 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1424889 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648788 30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler SCD 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539891 Breo Ellipta (fluticasone furoate 100 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539893 Breo Ellipta (fluticasone furoate 100 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539891 Breo Ellipta (fluticasone furoate 100 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539893 Breo Ellipta (fluticasone furoate 100 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648785 Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 14 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648789 Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648785 Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT) Dry Powder Inhaler, 14 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648789 Breo Ellipta (fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 2637476 Breo Ellipta (fluticasone furoate 50 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT)) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1539891 Breo Ellipta Institutional Pack SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648788 fluticasone furoate 200 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 2637473 fluticasone furoate 50 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT (as vilanterol trifenatate 40 MCG/ACTUAT) Dry Powder Inhaler, 30 ACTUAT SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28 1648788 fluticasone furoate/vilanterol 200/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters SY 96428df1-ea05-431a-98d3-1ec2c4b63878 28
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0173-0882-10 00173088210 1 TRAY in 1 CARTON (0173-0882-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER 1 tray 2015-04-30 0000-00-00 No No Current 0173-0882-14 00173088214 1 TRAY in 1 CARTON (0173-0882-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER 1 tray 2015-04-30 0000-00-00 No No Current 0173-0882-61 00173088261 1 TRAY in 1 CARTON (0173-0882-61) > 1 INHALER in 1 TRAY > 14 POWDER in 1 INHALER 1 tray 2015-04-30 0000-00-00 No No Current